- Home
- EDIT vs CHPT Comparison
EDIT vs CHPT Comparison
Compare EDIT & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- CHPT
- Stock Information
- Founded
- EDIT 2013
- CHPT 2007
- Country
- EDIT United States
- CHPT United States
- Employees
- EDIT N/A
- CHPT N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- CHPT Industrial Specialties
- Sector
- EDIT Health Care
- CHPT Consumer Discretionary
- Exchange
- EDIT Nasdaq
- CHPT Nasdaq
- Market Cap
- EDIT 269.8M
- CHPT 256.9M
- IPO Year
- EDIT 2016
- CHPT N/A
- Fundamental
- Price
- EDIT $2.40
- CHPT $7.75
- Analyst Decision
- EDIT Buy
- CHPT Hold
- Analyst Count
- EDIT 10
- CHPT 11
- Target Price
- EDIT $4.13
- CHPT $18.40
- AVG Volume (30 Days)
- EDIT 2.0M
- CHPT 447.5K
- Earning Date
- EDIT 11-10-2025
- CHPT 12-04-2025
- Dividend Yield
- EDIT N/A
- CHPT N/A
- EPS Growth
- EDIT N/A
- CHPT N/A
- EPS
- EDIT N/A
- CHPT N/A
- Revenue
- EDIT $46,383,000.00
- CHPT $397,731,000.00
- Revenue This Year
- EDIT N/A
- CHPT N/A
- Revenue Next Year
- EDIT N/A
- CHPT $12.67
- P/E Ratio
- EDIT N/A
- CHPT N/A
- Revenue Growth
- EDIT N/A
- CHPT N/A
- 52 Week Low
- EDIT $0.91
- CHPT $7.30
- 52 Week High
- EDIT $4.54
- CHPT $30.00
- Technical
- Relative Strength Index (RSI)
- EDIT 34.46
- CHPT 29.29
- Support Level
- EDIT $2.30
- CHPT $7.38
- Resistance Level
- EDIT $2.55
- CHPT $8.66
- Average True Range (ATR)
- EDIT 0.20
- CHPT 0.51
- MACD
- EDIT -0.00
- CHPT -0.15
- Stochastic Oscillator
- EDIT 20.00
- CHPT 16.86
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.